MEDICSKIN Forecasts Annual Profit Between 500,000 and 1.5 Million Hong Kong Dollars, Reversing Previous Loss

Stock News
Jun 12

The company anticipates recording a consolidated profit attributable to its owners in the range of approximately HK$500,000 to HK$1.5 million for the fiscal year ending March 31, 2026. This represents a significant turnaround from the net loss of about HK$3.4 million attributable to owners reported for the corresponding period in the previous year.

The board attributes this shift from loss to profitability primarily to two key factors. Firstly, the group's revenue for the year ending March 31, 2026, has increased compared to the prior year. This growth is credited to a rise in the number of clients using its treatment services and an increase in client visits for these services.

Secondly, the company achieved cost savings during the period. These savings included a reduction in rental expenses, which consequently lowered the depreciation of right-of-use assets, and a decrease in employee-related costs.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10